Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Tofilon

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Journal of Cellular and Molecular Medicine|July 16, 2010
Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102Ian M Buchanan, Tamalee Scott, Anita T Tandle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cellsThomas J Hayman, Amy Wahba, Barbara H Rath, et al.
Journal of Neuro-Oncology|October 15, 2020
Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere culturesJoseph H McAbee, Charlotte Degorre-Kerbaul, Kristin Valdez, et al.
Molecular Cancer Therapeutics|July 5, 2006
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cellsLorena de la Peña, William E Burgan, Donna J Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomideWhoon Jong Kil, David Cerna, William E Burgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone)Christopher A Barker, William E Burgan, Donna J Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularineHideaki Dote, David Cerna, William E Burgan, et al.
Molecular Cancer Therapeutics|April 14, 2004
Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX fociKevin Camphausen, Kristin J Brady, William E Burgan, et al.
Cancer Research|October 17, 2019
Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like CellsJoseph H McAbee, Barbara H Rath, Kristin Valdez, et al.
Neuro-Oncology Practice|November 8, 2018
Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastomaAndra V Krauze, Megan Mackey, Lindsay Rowe, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Cellular and Molecular Medicine|July 16, 2010
Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102Ian M Buchanan, Tamalee Scott, Anita T Tandle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cellsThomas J Hayman, Amy Wahba, Barbara H Rath, et al.
Journal of Neuro-Oncology|October 15, 2020
Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere culturesJoseph H McAbee, Charlotte Degorre-Kerbaul, Kristin Valdez, et al.
Molecular Cancer Therapeutics|July 5, 2006
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cellsLorena de la Peña, William E Burgan, Donna J Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomideWhoon Jong Kil, David Cerna, William E Burgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone)Christopher A Barker, William E Burgan, Donna J Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularineHideaki Dote, David Cerna, William E Burgan, et al.
Molecular Cancer Therapeutics|April 14, 2004
Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX fociKevin Camphausen, Kristin J Brady, William E Burgan, et al.
Cancer Research|October 17, 2019
Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like CellsJoseph H McAbee, Barbara H Rath, Kristin Valdez, et al.
Neuro-Oncology Practice|November 8, 2018
Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastomaAndra V Krauze, Megan Mackey, Lindsay Rowe, et al.
Pageof 9